KI-Beratung Beta
Vor Ort
Merkzettel Warenkorb
Produktbild: The Commercial Determinants of Health

The Commercial Determinants of Health

78,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

11.11.2022

Abbildungen

12 figures

Herausgeber

Nason Maani + weitere

Verlag

Oxford Academic

Seitenzahl

416

Maße (L/B/H)

23,3/15/2,8 cm

Gewicht

600 g

Sprache

Englisch

ISBN

978-0-19-757875-9

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

11.11.2022

Abbildungen

12 figures

Herausgeber

Verlag

Oxford Academic

Seitenzahl

416

Maße (L/B/H)

23,3/15/2,8 cm

Gewicht

600 g

Sprache

Englisch

ISBN

978-0-19-757875-9

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Ein neues Kapitel für Ihre Bücher

Ein neues Kapitel für Ihre Bücher

Schenken Sie Ihren alten Schätzen ein zweites Leben und erhalten Sie dafür eine Thalia Geschenkkarte.

Jetzt verkaufen
Jetzt verkaufen

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
Die Leseprobe wird geladen.
  • Produktbild: The Commercial Determinants of Health

    • Section 1: Why Commercial Determinants?
    • Chapter 1: Commercial Determinants of Health: An Introduction
    • Nason Maani, Mark Petticrew, and Sandro Galea
    • Chapter 2: A Systems Perspective on the Pathways of Influence between CDOH and Health
    • Cécile Knai and Natalie Savona
    • Chapter 3: Global Health and Equity Burden of Commercial Determinants of Health
    • Julia Anaf, Fran Baum, and Matt Fisher
    • Section 2: How Do Commercial Determinants Shape Upstream Drivers of Health?
    • Chapter 4: The Role of Policy in Studying the Commercial Determinants of Health
    • Benjamin Hawkins
    • Chapter 5: Understanding the Politics of the Commercial Determinants of Health
    • Eduardo J. Gómez
    • Chapter 6: The Role of Commercial Influences in Public Understanding of Harms, Causes and Solutions
    • Mark Petticrew, Nason Maani, and May van Schalkwyk
    • Chapter 7: The Role of Corporations in Influencing Culture
    • Nancy Tomes
    • Chapter 8: Industry Influence on Science: What Is Happening and What Can Be Done
    • Alice Fabbri and Anna Gilmore
    • Chapter 9: Role in Trade Deals and Investment
    • Pepita Barlow and Eric Crosbie
    • Section 3: Case Studies by Industry
    • Chapter 10: Hidden from View: Alcohol Industry Efforts to Keep the Epidemic of Alcohol-Related Harm from Public Awareness
    • Tim Stockwell and Erin Hobin
    • Chapter 11: Learning from 70 Years of Tobacco Control: Winning the War and Not Just the Battles
    • Anna B. Gilmore and Sarah Dance
    • Chapter 12: The Fossil Fuel Industry: Fuelling Doubt and Navigating Contradiction
    • May van Schalkwyk, Nason Maani, and Mark Petticrew
    • Chapter 13: The Gambling Industry: Harmful Products, Predatory Practices and the Politics of Knowledge
    • May van Schalkwyk and Rebecca Cassidy
    • Chapter 14: Sugar-Sweetened Beverages
    • Eric Crosbie, Laura Schmidt, Jim Krieger, and Marion Nestle
    • Section 4: Cross-Industry Mechanisms
    • Chapter 15: Marketing
    • Simone Pettigrew and Alexandra Jones
    • Chapter 16: Corporate Social Responsibility: Past, Present, and Future
    • Nino Paichadze, Vinu Ilakkuvan, Muluken Gizaw, and Adnan A. Hyder
    • Chapter 17: The Institutionalization of Corporate Power within Policy
    • Gary Fooks
    • Chapter 18: Corporations as Irresponsible Artificial People: Human Rights, Profits, and Public Health
    • George J. Annas
    • Chapter 19: Industry Influence on Research: A Cycle of Bias
    • Lisa Bero
    • Chapter 20: The Global Technology Sector as a Commercial Determinant of Health
    • Nora Kenworthy, Katerini Tagmatarchi Storeng, and Marco Zenone
    • Section 5: Advancing Science and Scholarship
    • Chapter 21: Defining the Commercial Determinants of Health
    • Jennifer Lacy-Nichols, Cassandra de Lacy-Vawdon, and Rob Moodie
    • Chapter 22: Assessing Power Structures
    • Joana Madureira Lima
    • Chapter 23: Rethinking Conflict of Interest: From Individual to Structural Understandings
    • Jeff Collin, Rob Ralston, and Sarah Hill
    • Chapter 24: Assessing the Health Impacts of the Commercial Determinants of Health
    • Luke N. Allen
    • Chapter 25: Assessing the Economic Impacts of Corporations
    • Martin McKee
    • Chapter 26: Prioritizing Research on the Foundational Drivers of Corporate Policy Influence
    • William H. Wiist
    • Chapter 27: The Influence of Commercial Industries on Public Discourse
    • Shona Hilton
    • Chapter 28: Commercial Determinants of Health in Low- and Middle-Income Countries
    • Salma M. Abdalla, Leona Ofei, Nason Maani, and Sandro Galea
    • Section 6: A Way Forward
    • Chapter 29: The Question of Industry Partnerships
    • Peter J. Adams
    • Chapter 30: Understanding and Managing Corporate Conflicts of Interest
    • Katherine Cullerton and Martin White
    • Chapter 31: Teaching the Commercial Determinants of Health
    • Nicholas Freudenberg and Eric Crosbie
    • Chapter 32: Learning from Experience: Identifying Key Intervention Points around Corporate Practices to Improve Health
    • Mélissa Mialon, Julia Anaf, and Fran Baum
    • Chapter 33: A Policy Agenda for the Commercial Determinants of Health
    • Sally Casswell
    • Chapter 34: Commercial Determinants of Health: A Research and Translational Agenda
    • Nason Maani, Mark Petticrew, and Sandro Galea
    • Index